Cited by 85Advanced MRI Techniques and ApplicationsBarrier Structure and Function StudiesAdvanced Neuroimaging Techniques and Applications

Subtle blood‐brain barrier leakage rate and spatial extent: Considerations for dynamic contrast‐enhanced MRI

Open access
van de Haar, Harm J., Jansen, Jacobus F.A., Jeukens, Cécile R.L.P.N., Burgmans, Saartje, van Buchem, Mark A., Muller, Majon, Hofman, Paul A.M., Verhey, Frans R.J. +2 more·2017·Medical Physics

Abstract

Purpose: Dynamic contrast‐enhanced (DCE) MRI can be used to measure blood‐brain barrier (BBB) leakage. In neurodegenerative disorders such as small vessel disease and dementia, the leakage can be very subtle and the corresponding signal can be rather noisy. For these reasons, an optimized DCE‐MRI measurement and study design is required. To this end, a new measure indicative of the spatial extent of leakage is introduced and the effects of scan time and sample size are explored. Methods: Dual‐time resolution DCE‐MRI was performed in 16 patients with early Alzheimer's disease (AD) and 17 healthy controls. The leakage rate (K i) and volume fraction of detectable leaking tissue (v L) to quantify the spatial extent of BBB leakage were calculated in cortical gray matter and white matter using noise‐corrected histogram analysis of leakage maps. Computer simulations utilizing realistic K i histograms, mimicking the strong effect of noise and variation in K i values, were performed to understand the influence of scan time on the estimated leakage. Results: The mean K i was very low (order of 10−4 min−1) and highly influenced by noise, causing the K i to be increasingly overestimated at shorter scan times. In the white matter, the K i was not different between patients with early AD and controls, but was higher in the cortex for patients, reaching significance after 14.5 min of scan time. To detect group differences, v L proved more suitable, showing significantly higher values for patients compared with controls in the cortex after 8 minutes of scan time, and in white matter after 15.5 min. Conclusions: Several ways to improve the sensitivity of a DCE‐MRI experiment to subtle BBB leakage were presented. We have provided v L as an attractive and potentially more time‐efficient alternative to detect group differences in subtle and widespread blood‐brain barrier leakage compared with leakage rate K i. Recommendations on group size and scan time are made based on statistical power calculations to aid future research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mp.12328

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent neuroimaging studies in individuals with MCI and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields, and several gray and white matter regions, before brain atrophy and dementia.

    “Recent neuroimaging studies in individuals with mild cognitive impairment (MCI) and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields (421), and several gray and white matter regions (220-222), respectively, before brain atrophy and dementia.”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [221]

    The Results report a greater fraction of detectable leaking tissue in cortical gray matter and normal-appearing white matter in patients with early AD than in controls. The paper does not establish that this leakage preceded brain atrophy or dementia; its study included patients already diagnosed with mild dementia or MCI due to AD (Imaging: subjects). The hippocampal subfields are attached to a different citation in the citing sentence. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497.
  2. Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K. Quantifica- tion of cerebral blood flow, cerebral blood volume, and blood-brain-bar- rier leakage with DCE-MRI. Magn Reson Med. 2009;62:205-217.
  3. Larsson HBW, Courivaud F, Rostrup E, Hansen AE. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 tesla. Magn Reson Med. 2009;62:1270-1281.
  4. Cramer SP, Larsson HBW. Accurate determination of blood-brain bar- rier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. J Cereb Blood Flow Metab. 2014;34:1655-1665.
  5. Khalifa F, Soliman A, El-Baz A, et al. Models and methods for analyz- ing DCE-MRI: a review. Med Phys. 2014;41:124301.
  6. Starr JM, Farrall AJ, Armitage P, McGurn B, Wardlaw JM. Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatry Res -Neuroimaging. 2009;171:232-241.
  7. Armitage PA, Farrall AJ, Carpenter TK, Doubal FN, Wardlaw JM. Use of dynamic contrast-enhanced MRI to measure subtle blood-brain bar- rier abnormalities. Magn Reson Imaging. 2011;29:305-314.
  8. Barnes SR, Ng TSC, Montagne A, Law M, Zlokovic BV, Jacobs RE. Optimal acquisition and modeling parameters for accurate assessment of low K trans blood-brain barrier permeability using dynamic contrast- enhanced MRI. Magn Reson Med. 2016;75:1967-1977.
  9. Taheri S, Gasparovic C, Huisa BN, et al. Blood-brain barrier permeabil- ity abnormalities in vascular cognitive impairment. Stroke. 2011;42:2158-2163.
  10. Taheri S, Gasparovic C, Shah NJ, Rosenberg GA. Quantitative measure- ment of blood-brain barrier permeability in human using dynamic con- trast-enhanced MRI with fast T1 mapping. Magn Reson Med. 2011;65:1036-1042.
  11. Bronge L, Wahlund L-OO. Contrast-enhanced MRI of White Matter Lesions in Patients with Blood-Brain Barrier Dysfunction. Dement Geri- atr Cogn Disord. 2000;11:477-481.
  12. van de Haar HJ, Burgmans S, Jansen JFA, et al. Blood-brain barrier leakage in early Alzheimer's disease. Radiology. 2016;281:527-535.
  13. Jelescu IO, Leppert IR, Narayanan S, Ara ujo D, Arnold DL, Pike GB. Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions. J Magn Reson Imaging. 2011;33:1291-1300.
  14. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341-355.
  15. de Boer R, Vrooman HA, van der Lijn F, et al. White matter lesion extension to automatic brain tissue segmentation on MRI. NeuroImage. 2009;45:1151-1161.
  16. Haroon HA, Buckley DL, Patankar TA, et al. A Comparison of Ktrans Measurements Obtained with Conventional and First Pass Pharmacoki- netic Models in Human Gliomas. J Magn Reson Imaging. 2004;19:527- 536.
  17. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative map- ping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging. 2000;12:347-357.
  18. Lavini C, Verhoeff JJC. Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input func- tion in the superior sagittal sinus in a patient population. Magn Reson Imaging. 2010;28:1420-1430.
  19. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol. 2006;41:213-221.
  20. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
  21. Aerts HJWL, Jaspers K, Backes WH. The precision of pharmacokinetic parameters in dynamic contrast-enhanced magnetic resonance imaging: the effect of sampling frequency and duration. Phys Med Biol. 2011;56:5665-5678.
  22. Zar JH. Biostatistical Analysis, 4th edn. Prentice Hall; 1999.
  23. McGrath DM, Bradley DP, Tessier JL, Lacey T, Taylor CJ, Parker GJM. Comparison of model-based arterial input functions for dynamic con- trast-enhanced MRI in tumor bearing rats. Magn Reson Med. 2009;61:1173-1184.
  24. Wardlaw JM, Sandercock PAG, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34:806-811.
  25. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17:509-520.
  26. Lee MH, Smyser CD, Shimony JS. Resting-state fMRI: a review of methods and clinical applications. Am J Neuroradiol. 2013;34:1866- 1872.
  27. Heye AK, Culling RD, Vald es Hern andez MDC, Thrippleton MJ, Ward- law JM. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin. 2014;6:262-274.
  28. Heye AK, Thrippleton MJ, Armitage PA, et al. Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability. NeuroImage. 2016;125:446-455.
  29. Cao Y, Li D, Shen Z, Normolle D. Sensitivity of Quantitative Metrics Derived from DCE MRI and a Pharmacokinetic Model to Image Quality and Acquisition Parameters. Acad Radiol. 2010;17:468-478.
  30. Kershaw LE, Cheng HLM. Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model. Magn Reson Med. 2010;64:1772-1780.
  31. Seelig A, Gottschlich R, Devant RM. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci USA. 1994;91:68-72.

Cited by

Sorted by citations

Authors
van de Haar, H. J., Jansen, J. F. A., Jeukens, C. R. L. P. N., Burgmans, S., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., van Osch, M. J. P., & Backes, W. H.
Affiliations
  • Department of Radiology and Nuclear Medicine Maastricht University Medical Center PO box 5800 Maastricht 6202 AZ The Netherlands
  • Maastricht University Medical Centre (NL)
  • Department of Radiology Leiden University Medical Center PO box 9600 Leiden 2300 RC The Netherlands
  • Leiden University Medical Center (NL)
Corresponding author
Backes, Walter H.
Venue
Medical Physics
Publisher
Wiley
Published
2017-07-10
Volume
44
Issue
8
Pages
4112-4125
ISSN
  • 0094-2405 (ISSN-L)
  • 2473-4209
OpenAlex
W2613536437
Cited by
85
References
4
Citations by year
2026: 4 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 17 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 7 · 2017: 2
FWCI
6.72
Type
journal article
Language
en
Open access
Locations
  • Medical Physics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Internationale Stichting Alzheimer Onderzoek (10553)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
Keywords
blood-brain barrier disruption, dynamic contrast-enhanced MRI, leakage rate, early Alzheimer's disease, cerebral small vessel disease, scan time, sample size, noise correction, histogram analysis, statistical power, cortical gray matter, white matter
MeSH terms
Blood-Brain Barrier, Contrast Media, Humans, Magnetic Resonance Imaging, White Matter, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review